ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,440 | -21.0% | 8,196 | -10.5% | 0.00% | 0.0% |
| Q2 2023 | $281,640 | -66.8% | 9,162 | -61.1% | 0.00% | -50.0% |
| Q1 2023 | $848,903 | -60.5% | 23,561 | -56.7% | 0.00% | -66.7% |
| Q4 2022 | $2,150,994 | -49.5% | 54,428 | -48.7% | 0.01% | -57.1% |
| Q3 2022 | $4,263,000 | +34.1% | 106,103 | +40.2% | 0.01% | +40.0% |
| Q2 2022 | $3,179,000 | +150.1% | 75,653 | +131.9% | 0.01% | +233.3% |
| Q1 2022 | $1,271,000 | +505.2% | 32,626 | +518.0% | 0.00% | – |
| Q4 2021 | $210,000 | +9.9% | 5,279 | 0.0% | 0.00% | – |
| Q3 2021 | $191,000 | -11.6% | 5,279 | 0.0% | 0.00% | – |
| Q2 2021 | $216,000 | -6.5% | 5,279 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $231,000 | – | 5,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |